Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancerbinding protein α with 13 years difference at onset

Haematologica

Volumn 98, Issue 7, 2013, Pages 73-74

  Debeljak, Maruša ^a   Kitanovski, Lidija ^a   Pajič, Tadej ^b   Jazbec, Janez ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA;

ACUTE MYELOBLASTIC LEUKEMIA; CASE REPORT; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HUMAN; LETTER; MONOZYGOTIC TWINS; POLYMERASE CHAIN REACTION; SOMATIC MUTATION;

ACUTE MYELOBLASTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; GERMLINE CEBPA MUTATIONS; MONOZYGOTIC TWINS;

ADOLESCENT; AGE FACTORS; CCAAT-ENHANCER-BINDING PROTEINS; FEMALE; FRAMESHIFT MUTATION; GERM-LINE MUTATION; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MUTAGENESIS, INSERTIONAL; SEQUENCE DELETION; TWINS, MONOZYGOTIC; YOUNG ADULT;

EID: 84879592651     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.082578     Document Type: Letter

References (10)

1. Senator H. Zur Kenntniss der Leukämie und Pseudoleukämie im Kindesalter. Berliner Klinische Wochenschrift. 1882;35:533-6.
2. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood. 2003;102(7):2321-33.
3. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer. 2003;3(9):639-49.
4. Clarkson B, Boyse EA. Possible explanation of the high concordance for acute leukaemia in monozygotic twins. Lancet. 1971;1(7701): 699-701.
5. Paz-Priel I, Friedman A. C/EBPα dysregulation in AML and ALL. Crit Rev Oncog. 2011;16(1-2):93-102.
6. Stelljes M, Corbacioglu A, Schlenk RF, Döhner K, Frühwald MC, Rossig C, et al. Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML. Leukemia. 2011;25(7): 1209-10.
7. Sellick GS, Spendlove HE, Catovsky D, Pritchard-Jones K, Houlston RS. Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia. Leukemia. 2005;19(7):1276-8.
8. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet. 2001;27(3):263-70.
9. Pabst T, Eyholzer M, Fos J, Mueller BU. Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis. Br J Cancer. 2009;100(8):1343-6.
10. Renneville A, Boissel N, Gachard N, Naguib D, Bastard C, de Botton S, et al. The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication. Blood. 2009;113(21):5090-3.